Structure-based identification of potent VEGFR-2 inhibitors from in vivo metabolites of a herbal ingredient

被引:0
|
作者
Raju Dash
Md. Junaid
Sarmistha Mitra
Md Arifuzzaman
S. M. Zahid Hosen
机构
[1] Molecular Modeling and Drug Design Laboratory,Department of Anatomy
[2] Pharmacology Research Division,Department of Biochemistry and Biotechnology
[3] Bangladesh Council of Scientific and Industrial Research (BCSIR),Plasma Bioscience Research Center, Plasma
[4] Dongguk University Graduate School of Medicine,bio display
[5] University of Science and Technology Chittagong,Department of Natural Sciences, LAGCC
[6] Kwangwoon University,undefined
[7] City University of New York (CUNY),undefined
来源
关键词
VEGFR-2; Angiogenesis; Molecular docking; Molecular dynamics; MM-PBSA;
D O I
暂无
中图分类号
学科分类号
摘要
Vascular endothelial growth factor receptor-2 (VEGFR-2) is one of the regulatory elements of angiogenesis that is expressed highly in various diseases and is also essential for solid tumor growth. The present study was aimed at identifying potent inhibitors of VEGFR-2 by considering herbal secondary metabolites; as natural molecules are less toxic than synthetic derivatives. A structure-based virtual screening protocol consisting of molecular docking, MM-GBSA and ADME/T analysis was initially used to screen a library of in vivo metabolites of the herbal ingredient. Using a fixed cutoff value, four potent virtual hits were identified from molecular docking, ADME/T and binding affinity calculations, which were considered further for molecular dynamics (MD) simulation to broadly describe the binding mechanisms to VEGFR-2. The results suggested that these molecules have high affinity for the catalytic region of VEGFR-2, and form strong hydrophobic and polar interactions with the amino acids involved in the binding site of ATP and linker regions of the catalytic site. Subsequently, the stability of the docked complexes and binding mechanisms were evaluated by MD simulations, and the energy of binding was calculated through MM-PBSA analysis. The results uncovered two virtual hits, designated ZINC14762520 and ZINC36470466, as VEGFR-2 inhibitors, and suggested that they bind to kinase domain in an ATP-competitive manner. These virtual hits will offer a suitable starting point for the further design of their various analogs, allowing a rational search for more effective inhibitors in the future.
引用
收藏
相关论文
共 50 条
  • [21] Identification and structure-based optimization of novel dihydropyrones as potent HCV RNA polymerase inhibitors
    Li, Hui
    Tatlock, John
    Linton, Angelica
    Gonzalez, Javier
    Borchardt, Allen
    Dragovich, Peter
    Jewell, Tanya
    Prins, Tom
    Zhou, Ru
    Blazel, Julie
    Parge, Hans
    Love, Robert
    Hickey, Michael
    Doan, Chau
    Shi, Stephanie
    Duggal, Rohit
    Lewis, Cristina
    Fuhrman, Shella
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (18) : 4834 - 4838
  • [22] Identification of Potent ADCK3 Inhibitors through Structure-Based Virtual Screening
    Gao, Peng
    Tambe, Mitali
    Chen, Catherine Z.
    Huang, Wenwei
    Tawa, Gregory J.
    Hirschhorn, Tal
    Stockwell, Brent R.
    Zheng, Wei
    Shen, Min
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2024, 64 (15) : 6072 - 6080
  • [23] Identification of new potent phthalazine derivatives with VEGFR-2 and EGFR kinase inhibitory activity
    Amin, Kamilia M.
    Barsoum, Flora F.
    Awadallah, Fadi M.
    Mohamed, Nehal E.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 123 : 191 - 201
  • [24] Discovery of novel Benzimidazoles as potent inhibitors of TIE-2 and VEGFR-2 tyrosine kinase receptors
    Hasegawa, Masaichi
    Nishigaki, Naohiko
    Washio, Yoshiaki
    Kano, Kazuya
    Harris, Philip A.
    Sato, Hideyuki
    Mori, Ichiro
    West, Rob I.
    Shibahara, Megumi
    Toyoda, Hiroko
    Wang, Liping
    Nolte, Robert T.
    Veal, James M.
    Cheung, Mui
    JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (18) : 4453 - 4470
  • [25] Novel quinoxaline-based VEGFR-2 inhibitors to halt angiogenesis
    Ismail, Magda M. F.
    Shawer, Taghreed Z.
    Ibrahim, Rabab S.
    Allam, Rasha M.
    Ammar, Yousry A.
    BIOORGANIC CHEMISTRY, 2023, 139
  • [26] A Review of Quinazoline-Based EGFR/VEGFR-2 Dual Inhibitors as Potent Anticancer Agents: Structure-Activity Relationship and Docking Studies
    Yousefbeyk, Fatemeh
    Ghasemi, Saeed
    PHARMACEUTICAL SCIENCES, 2025, 31 (01) : 43 - 64
  • [27] Structure-guided identification of novel VEGFR-2 kinase inhibitors via solution phase parallel synthesis
    Tripathy, R
    Reiboldt, A
    Messina, PA
    Iqbal, M
    Singh, J
    Bacon, ER
    Angeles, TS
    Yang, SX
    Albom, MS
    Robinson, C
    Chang, H
    Ruggeri, BA
    Mallamo, JP
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (08) : 2158 - 2162
  • [28] Fragment-based investigation of thiourea derivatives as VEGFR-2 inhibitors: a cross-validated approach of ligand-based and structure-based molecular modeling studies
    Banerjee, Suvankar
    Kejriwal, Shristi
    Ghosh, Balaram
    Lanka, Goverdhan
    Jha, Tarun
    Adhikari, Nilanjan
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2024, 42 (02): : 1047 - 1063
  • [29] Design and synthesis of VEGFR-2 inhibitors based on oleanolic acid moiety
    Song, Yan-Ling
    Zhang, Peng-Bo
    Tong, Rui-Jie
    Li, Ling
    Meng, Yan-Qiu
    JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH, 2021, 23 (02) : 176 - 188
  • [30] 1,2,3-Thiadiazole substituted pyrazolones as potent KDR/VEGFR-2 kinase inhibitors
    Tripathy, Rabindranath
    Ghose, Arup
    Singh, Jasbir
    Bacon, Edward R.
    Angeles, Thelma S.
    Yang, Shi X.
    Albom, Mark S.
    Aimone, Lisa D.
    Herman, Joseph L.
    Mallamo, John P.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (06) : 1793 - 1798